Lv2
200 积分 2023-05-10 加入
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
11天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
8个月前
已完结
385MO A multicenter, open-label, dose escalation and expansion study of DP303c in patients with HER2-positive pre-treated advanced solid tumors
9个月前
已完结
基于遗传神经网络的抗肿瘤药物不良反应诊断系统
1年前
已完结
潮河古北口断面的污染物通量估算及水质评价
1年前
已关闭
Mechanisms of Dupilumab
1年前
已完结
Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study
1年前
已完结
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
1年前
已完结
D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients With NSCLC: Phase 1 Study Results
1年前
已完结
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
1年前
已完结
A novel pH-responsive flocculant for efficient separation and recovery of Cu and Mo from secondary resources via selective flocculation-flotation
1年前
已采纳
Transformation of macrolide antibiotics during chlorination process: Kinetics, degradation products, and comprehensive toxicity evaluation
1年前
已采纳
皖公网安备34019202002308
